Department of Orthopaedic Surgery, Division of Physical Medicine and Rehabilitation, Stanford University, Palo Alto, CA 94305, USA.
Department of Physical Medicine and Rehabilitation, Kaiser Permanente San Rafael Medical Center, San Rafael, CA 94903, USA.
Spine J. 2022 Jul;22(7):1106-1111. doi: 10.1016/j.spinee.2022.02.006. Epub 2022 Feb 15.
Spinal corticosteroid injections (CSI) are often used to treat radicular and axial pain arising from the spine. Systemic corticosteroids are well known to cause immunosuppression, and locally injected spinal CSI are known to have some systemic absorption. However, it is unknown whether spinal CSI increases the risk of systemic viral infections, such as influenza.
To determine whether spinal CSI causes an increased risk for influenza infection and whether they reduce the protective effect of vaccination STUDY DESIGN/SETTING: A retrospective cohort study was performed at Kaiser Permanente Northern California, a large healthcare system with a diverse population.
Adults (n=60,880) who received a spinal CSI during influenza seasons from 2016 to 2019. A comparison was made with 121,760 case-matched individuals who did not receive a spinal CSI.
The primary outcome was odds of influenza diagnosis following spinal CSI compared with case-matched controls. Secondary analysis examined odds of influenza diagnosis based on vaccination status, multiple same-day injections, and epidural versus non-epidural route of injection.
The electronic health record and associated research databases were analyzed to identify patients who received a spinal CSI during three consecutive flu seasons, 2016 through 2019. Injections were stratified into epidural versus non-epidural CSI and single injections versus multiple same-day injections. Additionally, the rate of influenza in vaccinated versus non-vaccinated individuals was examined. Inpatient flu diagnosis was used as a proxy for severe disease. After case matching was completed, odds ratios for flu diagnosis were calculated using a logistical regression model.
The odds of flu diagnosis following spinal CSI were not increased compared with controls (OR 0.93 [0.87-1.01, 95% Wald CL]). For epidural CSI the OR was 0.91 (0.83-1.00, 95% Wald CL), and non-epidural it was 1.00 (0.89-1.13, 95% Wald CL). There were similar findings for multiple same-day injections and when looking at inpatient flu diagnosis. For vaccinated individuals, the OR for flu following spinal CSI was 0.86 (0.80-0.92, 95% Wald CL), which indicates a protective effect in these patients.
Spinal CSI did not increase the odds of subsequently receiving a diagnosis of influenza, regardless of vaccination status, location of injection, single versus multiple same-day injection, or co-morbidity. Vaccination had a protective effect against influenza, and this was not adversely affected by receiving spinal CSI during the flu season.
脊柱皮质类固醇注射(CSI)常用于治疗脊柱引起的神经根性和轴性疼痛。众所周知,全身皮质类固醇会引起免疫抑制,而局部注射的脊柱 CSI 会有一定程度的全身吸收。然而,目前尚不清楚脊柱 CSI 是否会增加流感等全身病毒感染的风险。
确定脊柱 CSI 是否会增加流感感染的风险,以及它们是否会降低疫苗接种的保护作用。
研究设计/地点:这是一项在 Kaiser Permanente Northern California 进行的回顾性队列研究,该机构是一个拥有多样化人群的大型医疗保健系统。
2016 年至 2019 年流感季节期间接受脊柱 CSI 的成年人(n=60880)。将他们与 121760 名未接受脊柱 CSI 的匹配个体进行比较。
主要结局是与匹配对照组相比,脊柱 CSI 后流感诊断的比值比。二次分析根据疫苗接种状态、多次同日注射以及硬膜外与非硬膜外注射途径,检查流感诊断的比值比。
分析电子健康记录和相关研究数据库,以确定在三个连续流感季节(2016 年至 2019 年)期间接受脊柱 CSI 的患者。将注射分为硬膜外与非硬膜外 CSI 以及单次注射与多次同日注射。此外,还检查了疫苗接种者与未接种者的流感发病率。住院流感诊断被用作严重疾病的替代指标。完成病例匹配后,使用逻辑回归模型计算流感诊断的比值比。
与对照组相比,脊柱 CSI 后流感诊断的比值比没有增加(比值比 0.93[0.87-1.01,95% Wald CL])。硬膜外 CSI 的比值比为 0.91(0.83-1.00,95% Wald CL),而非硬膜外 CSI 的比值比为 1.00(0.89-1.13,95% Wald CL)。多次同日注射和住院流感诊断也有类似的发现。对于疫苗接种者,脊柱 CSI 后流感的比值比为 0.86(0.80-0.92,95% Wald CL),这表明这些患者具有保护作用。
无论疫苗接种状态、注射部位、单次与多次同日注射或合并症如何,脊柱 CSI 均不会增加随后诊断为流感的几率。疫苗接种对流感具有保护作用,而在流感季节接受脊柱 CSI 并不会对其产生不利影响。